GDBspace, a Space Pharmaceuticals company specialized in computational methods for drug discovery, was selected by the Swiss Innovation Council, together with Swissnex, to represent Swiss innovations in the USA and obtained related support for market entry into the US market.
The Swiss companies selected are: CareerFairy, EraCal Therapeutics, GDBspace, Genistat, HAYA Therapeutics, Hydromea, Iazzu, Pexapark, Securaxis, Seervision, SurgeonsLab.
Dr. Jingwen Shi, CBO at Space Pharmaceuticals said “We are really excited to be part of the US market entry bootcamp! What we want to achieve with Swissnex is to navigate the US (Boston and San Francisco) ecosystem, from strategic topics like what is our best market entry strategy to practical questions such as tax implications”.